0
0
0
Insulin for All Act of 2023
3/14/2024, 4:05 AM
Summary of Bill HR 1485
The Insulin for All Act of 2023, also known as Bill 118 hr 1485, is a piece of legislation introduced in the US Congress with the goal of making insulin more affordable and accessible for all Americans. The bill aims to address the rising costs of insulin, which have become a major burden for many individuals with diabetes.
Under the provisions of the Insulin for All Act, the government would negotiate with insulin manufacturers to set a maximum price for insulin that is affordable for all individuals, regardless of their insurance coverage. This would help to ensure that no one is forced to ration their insulin or go without this life-saving medication due to cost.
Additionally, the bill includes measures to increase transparency in the pricing of insulin, as well as provisions to expand access to affordable insulin for individuals who are uninsured or underinsured. It also seeks to promote research and development of new, more affordable insulin products. Overall, the Insulin for All Act of 2023 aims to address the growing crisis of insulin affordability in the United States and ensure that all individuals with diabetes have access to the medication they need to manage their condition effectively.
Under the provisions of the Insulin for All Act, the government would negotiate with insulin manufacturers to set a maximum price for insulin that is affordable for all individuals, regardless of their insurance coverage. This would help to ensure that no one is forced to ration their insulin or go without this life-saving medication due to cost.
Additionally, the bill includes measures to increase transparency in the pricing of insulin, as well as provisions to expand access to affordable insulin for individuals who are uninsured or underinsured. It also seeks to promote research and development of new, more affordable insulin products. Overall, the Insulin for All Act of 2023 aims to address the growing crisis of insulin affordability in the United States and ensure that all individuals with diabetes have access to the medication they need to manage their condition effectively.
Congressional Summary of HR 1485
Insulin for All Act of 2023
This bill caps the manufacturer price of insulin at $20 per 1,000 units.
Read the Full Bill
Current Status of Bill HR 1485
Bill HR 1485 is currently in the status of Bill Introduced since March 9, 2023. Bill HR 1485 was introduced during Congress 118 and was introduced to the House on March 9, 2023. Bill HR 1485's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 9, 2023
Bipartisan Support of Bill HR 1485
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
38Democrat Cosponsors
38Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 1485
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 1485
Insulin for All Act of 2023
Insulin for All Act of 2023
To limit the price charged by manufacturers for insulin.
Comments
Sponsors and Cosponsors of HR 1485
Latest Bills
RISE Act
Bill S 3589August 14, 2026
Federal Building Threat Notification Act
Bill S 2542August 14, 2026
A bill to require the United States Postal Service to designate ZIP Codes for certain communities.
Bill S 4505August 14, 2026
A bill to expand the sharing of information with respect to suspected violations of intellectual property rights in trade.
Bill S 2677August 14, 2026
USMMA Athletics Act of 2026
Bill S 3266August 13, 2026
Space Commerce Advisory Committee Act
Bill S 434August 13, 2026
Diversity Jurisdiction Inflation Adjustment Act
Bill S 4850August 13, 2026
Officer John Barnes and Chief Michael Ansbro Public Safety Officers' Benefit Program Expansion Act of 2026
Bill S 3897August 13, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784August 13, 2026
Cahokia Mounds Mississippian Culture Study Act
Bill S 1516August 13, 2026
Insulin for All Act of 2023
Bill S 727December 15, 2023





